Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Haemonetics Corporation    HAE

HAEMONETICS CORPORATION

(HAE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

HAEMONETICS CORP : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
06/30/2020 | 05:33pm EDT

Item 3.03. Material Modification to Rights of Security Holders.

On June 29, 2020, the Board of Directors (the "Board") of Haemonetics Corporation (the "Company") amended the Company's By-Laws (the "By-Laws"), effective immediately, by amending Article IV, Place of Shareholders' Meetings, to permit the conduct of meetings of shareholders by remote communications to the extent permitted by applicable law.

The description above of the amendment to the Company's By-Laws does not purport to be complete and is qualified in its entirety by reference to the full text of the By-Laws, attached as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The information set forth in Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On June 30, 2020, the Company issued a press release announcing that its 2020 Annual Meeting of Shareholders will be conducted in virtual format at the previously announced date and time of July 21, 2020 at 8:00 a.m. Eastern Time, in light of the public health impact of the coronavirus pandemic (COVID-19) and to support the health and well-being of the Company's shareholders, employees and directors.

A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
Number              Description
        3.1         By-Laws of the Company, as amended through June 29, 2020
                    Text of Amendments to By-Laws of the Company effective June 29, 2020 (shown in
        3.2         marked text)
       99.1         Press Release, dated June 30, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
Latest news on HAEMONETICS CORPORATION
04:18pHAEMONETICS SETS DATE FOR PUBLISHING : August 4, 2020
PR
07/02HAEMONETICS CORP : Regulation FD Disclosure (form 8-K)
AQ
06/30HAEMONETICS CORP : Material Modification to Rights of Security Holders, Amendmen..
AQ
06/30HAEMONETICS : Announces 2020 Annual Meeting Of Shareholders Will Be Conducted In..
PR
06/30HAEMONETICS CORP : Regulation FD Disclosure (form 8-K)
AQ
06/11HAEMONETICS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
06/03HAEMONETICS : Announces Blood Filter Supply Agreement And Sale Of Puerto Rico-Ba..
PR
06/01HAEMONETICS : Jefferies Virtual Healthcare Conference Presentation
PU
05/28HAEMONETICS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
05/28HAEMONETICS : Announces Sale Of U.S. Blood Donor Management Software Solution As..
PR
More news